Improved treatment satisfaction with once-weekly insulin icodec versus once-daily insulin degludec in basal insulin-treated type 2 diabetes (ONWARDS 2)

被引：0
|
作者：
Polonsky, W. [1 ]
Benamar, M. [2 ]
Carstensen, L. [2 ]
Davies, M. [3 ]
Donatsky, A. M. [2 ]
Franek, E. [4 ]
Kellerer, M. [5 ]
Goldenberg, R. [6 ]
机构：
[1] Behav Diabet Inst, San Diego, CA USA
[2] Novo Nordisk AS, Soborg, Denmark
[3] Univ Leicester, Diabet Res Ctr, Leicester, Leics, England
[4] Minist Interior, Cent Clin Hosp, Warsaw, Poland
[5] Marien Hosp, Clin Internal Med, Stuttgart, Germany
[6] LMC Diabet & Endocrinol, Concord, ON, Canada
来源：
DIABETOLOGIA | 2023年 / 66卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
780
引用
收藏
页码：S400 / S400
页数：1
相关论文
共 50 条
  • [31] Insulin icodec: an insulin analogue suited for once-weekly dosing in type 2 diabetes
    Hovelmann, U.
    Brondsted, L.
    Kristensen, N. R.
    Ribel-Madsen, R.
    DeVries, J. H.
    Heise, T.
    Haahr, H.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S316 - S316
  • [32] Cost-utility analysis of once-weekly insulin icodec and once-daily insulin glargine in patients with type 2 diabetes receiving basal-bolus insulin therapy in China
    Dai, Nan
    Su, Xiaorong
    Wang, Yong
    DIABETES OBESITY & METABOLISM, 2025, 27 (01): : 377 - 386
  • [33] The effect of once-weekly insulin icodec vs once-daily basal insulin on physical activity-attributed hypoglycaemia in type 2 diabetes: a post hoc analysis of ONWARDS 1-5
    Riddell, Michael C.
    Heller, Simon
    Carstensen, Lisbeth
    Rocha, Thais M. Pagliaro
    Watt, Sara Kehlet
    Woo, Vincent C.
    DIABETOLOGIA, 2025,
  • [34] No Evidence of Increased Physical Activity-Related Hypoglycemia with Once-Weekly Insulin Icodec vs. Once-Daily Basal Insulin in Type 2 Diabetes-ONWARDS 1-5
    Riddell, Michael C.
    Heller, Simon R.
    Asong, Marisse
    Carstensen, Lisbeth
    Watt, Sara K.
    Woo, Vincent C.
    DIABETES, 2024, 73
  • [35] Efficacy and safety of once-weekly basal insulin versus once-daily basal insulin in patients with type 2 diabetes: A systematic review and meta-analysis
    Wang, Xinxin
    Xiao, Wei
    Liang, Zhanpeng
    Li, Shixiang
    Tang, Qizhi
    MEDICINE, 2023, 102 (52) : E36308
  • [36] No Evidence of Increased Physical Activity-Related Hypoglycemia with Once-Weekly Insulin Icodec vs. Once-Daily Basal Insulin in Type 1 Diabetes-ONWARDS 6
    Sourij, Harald
    Bracken, Richard M.
    Asong, Marisse
    Carstensen, Lisbeth
    Watt, Sara K.
    Philis-Tsimikas, Athena
    DIABETES, 2024, 73
  • [37] Icodec: A Novel Once-Weekly Basal Insulin for Diabetes Management
    Goldman, Jennifer
    Triplitt, Curtis
    Isaacs, Diana
    ANNALS OF PHARMACOTHERAPY, 2024,
  • [38] Insulin icodec: A novel once-weekly treatment for diabetes
    Schaffner, Hannah
    Wiener, Jordyn
    Deluca, Amanda
    Genovese, Ariana
    Deeb, Alexander
    Deeb, Wasim
    Sheikh-Ali, Mae
    Sutton, David
    Gore, Ashwini
    Berner, Jason
    Huston, Jessica
    Goldfaden, Rebecca
    DIABETIC MEDICINE, 2024, 41 (10)
  • [39] Once-Weekly Insulin Icodec With Dosing Guide App Versus Once-Daily Basal Insulin Analogues in Insulin-Naive Type 2 Diabetes (Sept, 10.7326/M23-1288, 2023)
    Bajaj, H. S.
    Aberle, J.
    Davies, M.
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (12) : 1688 - 1688
  • [40] Efficacy and Safety Outcomes with Once-Weekly Insulin Icodec vs. Once-Daily Insulin Degludec in Type 1 Diabetes According to Glycemic Variability-ONWARDS 6 Post Hoc Analysis
    Irace, Concetta
    Begtrup, Kamilla
    Marques, Mariana Fragao
    Watt, Sara K.
    Klonoff, David C.
    DIABETES, 2024, 73
12345